Evidence map›Paper›PMID 34823507›Full record

ReviewBMC women's health2021

Triple-negative apocrine carcinoma as a rare cause of a breast lump in a Syrian female: a case report and review of the literature.

Sawsan Ismail, Haidara Kherbek, Jana Skef, Nadim Zahlouk, Rafik Abdulal, Zuheir Alshehabi

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in BMC women's health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sawsan IsmailDepartment of Pathology, Faculty of Medicine, Tishreen University, Lattakia, Syria. sawsanismail8@gmail.com.ORCID 0000-0001-5049-1598
Haidara KherbekFaculty of Medicine, Tishreen University, Lattakia, Syria.
Jana SkefFaculty of Medicine, Tishreen University, Lattakia, Syria.
Nadim ZahloukDepartment of Oncology, Tishreen University Hospital, Lattakia, Syria.
Rafik AbdulalDepartment of General Surgery, Al Nada Surgical Hospital, Lattakia, Syria.
Zuheir AlshehabiDepartment of Pathology, Cancer Research Center, Tishreen University, Lattakia, Syria.
Latakia University · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApocrine carcinoma is a rare tumor that constitutes < 4% of all breast malignancies, characterized by the proliferation of large atypical cells with strictly defined borders, abundant eosinophilic cytoplasm, large nuclei, and prominent nucleoli in more than 90% of tumor cells. Triple-negative apocrine carcinoma is a rare molecular subtype that constitutes less than 1% of triple-negative breast cancers and is characterized by negative expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor, with positive expression of androgen receptor. CASE PRESENTATION: We report a case of a 45-year-old Syrian female who presented to our hospital due to a painless palpable mass in her left breast. Following physical and radiological examinations, an excisional biopsy was performed. Microscopic examination of the specimen followed by immunohistochemical staining revealed the diagnosis of a triple-negative apocrine carcinoma.

conclusionTriple-negative apocrine carcinoma is an extremely rare neoplasm that must be considered in the differential diagnoses of breast lesions through detailed clinical, histological, and immunohistochemical correlations. In our manuscript, we aimed to present the first case report of a Syrian female who was diagnosed with a triple-negative apocrine carcinoma, aiming to highlight the importance of detailed clinical, histological and immunohistochemical correlations with a detailed review of diagnostic criteria, molecular characteristics, and treatment recommendations.

Indexed as

Breast NeoplasmsCarcinomaTriple Negative Breast NeoplasmsBiomarkers, TumorFemaleHumansImmunohistochemistryMiddle AgedSyriaBiomarkers, TumorApocrine carcinomaApocrine differentiationBreast CancerImmunohistochemistryTriple-negative apocrine carcinoma

Identifiers

PMID34823507
PMCPMC8613959
OpenAlexW3217185436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.